Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium sulphate to prevent supraventricular dysrhythmias after non-cardiac thoracic surgery
2004-002818-11Phase 4Unknown
- Sponsor
- Heart of England NHS Foundation Trust
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of magnesium sulfate in supraventricular tachycardia (SVT) and Supraventricular arrhythmia (SVA), sponsored by Heart of England NHS Foundation Trust. Primary endpoint: Incidence of post-thoracotomy supraventricular dysrhythmias. Status: unknown.
02
Drugs
magnesium sulfate
03
Conditions
supraventricular tachycardia (SVT)Supraventricular arrhythmia (SVA)
Beyond the preview
Go deeper on 2004-002818-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002818-11.